The goals of the Clinical Core are to enhance the quality of AIDS research at CWRU and at collaborating centers by achieving the following specific aims: 1. Maintaining and expanding a comprehensive and accessible patient care database (the SIU database) that both facilitates clinical management and serves as a robust resource for clinical investigation. 2. Maintaining and expanding a specimen repository linked to the patient care database that provides researchers ready access to stored samples linked to a comprehensive patient care data set. 3. Capitalizing on the resources of the user-friendly SIU database, a clinical studies coordinator provides researchers access to patients pre-selected for interest and identified as eligible (through review of the SIU database) to participate in HIV clinical research through clinical trials or other research studies. The goal of this core is to facilitate clinical and translational research. The three key resources of this core facilitate research activities through seamless and rapid access to clinical information and clinical material. This clinical core is remarkable among HIV research facilities for the comprehensive and ready access that is provided to clinical samples, to interested patients and to readily accessible clinical data. The CFAR Clinical Core comprises three key, interrelated resources: CWRU/UHC CFAR SIU database, SIU specimen repository; and clinical studies access coordination. In the coming period, this core seeks to: 1. Test the feasibility of expanding the database resource to other developing nations in collaboration with the CWRU/UHC Ugandan Laboratory Core and the Epidemiology Biostatistics Core by establishing the CFAR Database in Kampala, Uganda. This project will also include the training of staff and investigators. 2. Increase the number of CWRU/UHC CFAR investigators and investigators at other CFARS and outside institutions who will utilize CFAR Clinical Core Resources through expanded outreach. 3. Help to build and lead the CFAR collaborative C-NICS project which is presently establishing a large centralized database and prospective cohort at 6 CFAR sites. 4. Expand the repository of viably cryopreserved PBMC to include annual storage of samples obtained from all consenting SIU patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036219-14
Application #
7491114
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
14
Fiscal Year
2007
Total Cost
$269,334
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Silver, Nicholas; Paynter, Mary; McAllister, Georgina et al. (2018) Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay. AIDS Res Ther 15:18
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Martinez, Leonardo; Handel, Andreas; Shen, Ye et al. (2018) A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts. Am J Respir Crit Care Med 197:1214-1216
Fitzgerald, Wendy; Freeman, Michael L; Lederman, Michael M et al. (2018) A System of Cytokines Encapsulated in ExtraCellular Vesicles. Sci Rep 8:8973
Dazard, Jean-Eudes; Ishwaran, Hemant; Mehlotra, Rajeev et al. (2018) Ensemble survival tree models to reveal pairwise interactions of variables with time-to-events outcomes in low-dimensional setting. Stat Appl Genet Mol Biol 17:
Mukherjee, Pranab K; Chandra, Jyotsna; Retuerto, Mauricio et al. (2018) Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection. PLoS One 13:e0200285
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Tomalka, Amanda G; Resto-Garay, Ivelisse; Campbell, Kerry S et al. (2018) In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol 9:2552
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786

Showing the most recent 10 out of 539 publications